Brodalumab Subcutaneous and Morphine Immediate-Release Tablets and Capsules
Determining the interaction of Brodalumab Subcutaneous and Morphine Immediate-Release Tablets and Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Morphine injection
- Brodalumab Subcutaneous-Morphine Injection PF
- Brodalumab Subcutaneous-Morphine Long-Acting Tablets
- Brodalumab Subcutaneous-Morphine Oral Concentrate (20 mg/mL)
- Brodalumab Subcutaneous-Morphine Oral Solution
- Brodalumab Subcutaneous-Morphine Sulfate
- Morphine Immediate-Release Tablets and Capsules-Brodspec
- Morphine Immediate-Release Tablets and Capsules-Brom Mal Phenyl HCl Dex HBr
- Morphine Immediate-Release Tablets and Capsules-Bromaline
- Morphine Immediate-Release Tablets and Capsules-Bromaline DM
- Morphine Immediate-Release Tablets and Capsules-Bromatan Plus
- Morphine Immediate-Release Tablets and Capsules-Bromatan-DM